Literature DB >> 12081832

Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.

Pauline A L Ashfield-Watt1, Catherine H Pullin, Jane M Whiting, Zoë E Clark, Stuart J Moat, Robert G Newcombe, Michael L Burr, Malcolm J Lewis, Hilary J Powers, Ian F W McDowell.   

Abstract

BACKGROUND: Low folate status and elevated plasma homocysteine are associated with increased risk of neural tube defects and cardiovascular disease. Homocysteine responses to folate may be influenced by genetic variants in folate metabolism.
OBJECTIVE: We determined the effect of folate-enhancing dietary interventions on plasma folate and plasma total homocysteine (tHcy) with respect to the methylenetetrahydrofolate reductase 677C-->T genotype.
DESIGN: A total of 126 healthy subjects (42 TT, 42 CT, and 42 CC genotypes) completed 3 dietary interventions (4 mo each) in random order: 1) exclusion diet (avoidance of folic acid-fortified foods and ingestion of a placebo daily), 2) folate-rich diet (increased intake of fortified and naturally folate-rich foods to achieve 400 microg folate/d), and 3) supplement (exclusion diet plus a folate supplement of 400 microg/d).
RESULTS: Plasma folate was higher (P < or = 0.001) and plasma tHcy lower (P < or = 0.001) after the folate-rich and supplement interventions than after the exclusion diet. Plasma folate was significantly greater after supplementation than after the folate-rich diet, but there was no significant difference in tHcy concentration (P = 0.72). TT homozygotes had higher plasma tHcy (14.5 compared with 8.9 micromol/L, P < or = 0.001) and lower plasma folate (14.8 compared with 19.0 nmol/L, P < or = 0.01) than did subjects with the CC genotype after the exclusion diet. CT heterozygotes had intermediate concentrations. The trend toward higher tHcy in TT homozygotes persisted throughout the study but was less marked with increasing folate intake (TT compared with CC after supplementation, P = 0.097).
CONCLUSIONS: A folate-rich diet including folic acid-fortified foods or low-dose supplements effectively increases folate status. TT homozygotes require higher folate intakes than do individuals with the CT or CC genotype to achieve similar tHcy concentrations but are responsive to folate intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081832     DOI: 10.1093/ajcn/76.1.180

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  27 in total

Review 1.  Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors:  Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Folate bioavailability: implications for establishing dietary recommendations and optimizing status.

Authors:  Marie A Caudill
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

3.  Nutrigenomic Information in the openEHR Data Set.

Authors:  Priscila Alves Maranhão; Gustavo Marísio Bacelar-Silva; Duarte Nuno Gonçalves Ferreira; Conceição Calhau; Pedro Vieira-Marques; Ricardo João Cruz-Correia
Journal:  Appl Clin Inform       Date:  2018-03-28       Impact factor: 2.342

Review 4.  Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

Authors:  Sarah J Lewis; Shah Ebrahim; George Davey Smith
Journal:  BMJ       Date:  2005-10-10

5.  Paraquat Exposure Increases Oxidative Stress Within the Dorsal Striatum of Male Mice With a Genetic Deficiency in One-carbon Metabolism.

Authors:  Nafisa M Jadavji; Lauren K Murray; Joshua T Emmerson; Chris A Rudyk; Shawn Hayley; Patrice D Smith
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

6.  Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial.

Authors:  Cheryl A M Anderson; Shirley A A Beresford; Dale McLerran; Johanna W Lampe; Samir Deeb; Ziding Feng; Arno G Motulsky
Journal:  Mol Nutr Food Res       Date:  2013-03-04       Impact factor: 5.914

7.  Folic acid and prevention of neural tube defects.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

Review 8.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 9.  Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer.

Authors:  S M Langevin; D Lin; K Matsuo; C M Gao; T Takezaki; R Z Stolzenberg-Solomon; M Vasavi; Q Hasan; E Taioli
Journal:  Toxicol Lett       Date:  2008-09-16       Impact factor: 4.372

10.  The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies.

Authors:  Natalie J Colson; Helen L Naug; Elham Nikbakht; Ping Zhang; Joanna McCormack
Journal:  Eur J Nutr       Date:  2015-10-23       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.